[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
August 9, 2000

Estrogen-Progestin Replacement and Risk of Breast Cancer

Author Affiliations
 

Stephen J.LurieMD, PhD, Contributing EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor

JAMA. 2000;284(6):691-694. doi:10.1001/jama.284.6.691

To the Editor: Dr Schairer and colleagues1 conclude that the estrogen-progestin regimen is associated with higher risks of breast cancer than estrogen alone. However, several aspects of the study deserve careful consideration.

First, the study was not conducted in a representative sample of women but in a select population for whom the risk of breast cancer may be high. Only a sample of women who had neither surgery nor the recommendation for it at baseline were included in the analysis. Furthermore, type of hormone used was not assessed in the first phase of follow-up. Some hormone use was measured retrospectively, possibly introducing recall bias.2 Moreover, the authors report no results for women who had mammography regularly.

First Page Preview View Large
First page PDF preview
First page PDF preview
×